News | October 12, 2021
Skanray to raise Rs 400 crore to fund its inorganic growth
Since its inception, the company has either acquired or taken a majority stake in five companies
Since its inception, the company has either acquired or taken a majority stake in five companies
The drug is being developed at lab scale for the first-line of treatment of Covid-19
_256_384.jpeg)
The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio
Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients
_256_384.jpg)
Indian Chemical News, an online news media covering Pharma, Chemical and Petrochemical sector is organizing an E-conference on “India's Pharma Industry Outlook 2021” on 12th February, 2021 from 3:00 PM – 4:30 PM.
The event showcased latest breakthroughs in minimally invasive surgery, organ-preservation strategies, and targeted therapies
In his new role, he is expected to further strengthen Zenex Animal Health’s market position and accelerate its next phase of growth.
Three-day programme equips CSIR researchers with advanced AI tools, molecular docking insights, and biomolecular simulation expertise
A major highlight of the event was the launch of several publications and digital initiatives, including a certification course on the Ayush Grid portal
Discussions are likely to centre on how the country can move up the pharmaceutical value chain
Subscribe To Our Newsletter & Stay Updated
